• Acridine Orange hydrochloride: Practical Guide

  2026-08-28

  Acridine Orange hydrochloride provides a dual-emission approach for nucleic acid visualization in intact-cell cytochemistry and flow workflows, helping distinguish green and red fluorescence associated with different nucleic acid states. It should be optimized with assay-specific controls and should not be treated as a standalone proof of apoptosis, transcriptional activity, or DNA/RNA identity.

• NVP-BGJ398 Phosphate: Translational FGFR Strategy

  2026-08-28

  NVP-BGJ398 phosphate offers a research framework for connecting FGFR1–3 biology with genotype-selected cancer models and FGFR3-driven skeletal disease. This article moves beyond product specifications to show how pathway pharmacology, tissue-level validation, and translational study design can be integrated.

• CFDA-SE Workflows for Proliferation and Migration

  2026-08-28

  CFDA-SE turns intracellular esterase activity into a division-sensitive fluorescent record for viable cells. This practical guide shows how to combine proliferation history with migration and surfaceome experiments without confusing a phenotypic readout with a molecular interaction map.

• EPI-001: Androgen Receptor N-Terminal Inhibition

  2026-08-27

  EPI-001 is an androgen receptor N-terminal domain inhibitor for studying ligand-dependent and ligand-independent signaling in prostate cancer, CRPC, and selected AR/ARv7-positive models. This practical guide connects formulation, dose-response, migration, molecular readouts, and troubleshooting to help distinguish pathway inhibition from nonspecific cytotoxicity.

• Z-WEHD-FMK in Caspase-1 Research

  2026-08-26

  Z-WEHD-FMK, also known as Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK, is a cell-permeable irreversible inhibitor of inflammatory caspases. Its documented use in Chlamydia-infected HeLa cells provides a practical starting point for studying caspase signaling, Golgi fragmentation, pyroptosis, and host–pathogen interactions.

• From Cholesterol Mapping to Fibrosis Mechanism

  2026-08-26

  Filipin III can connect membrane cholesterol biology with translational questions in PHMG-induced pulmonary fibrosis. By pairing cholesterol-sensitive imaging with the reported SOAT1–lipophagy–foam-cell mechanism, researchers can move beyond descriptive lipid staining toward spatially resolved, experimentally testable disease biology.

• Single-Cell Ciprofloxacin–Tetracycline Antagonism

  2026-08-26

  The reference study uses microfluidic single-cell analysis to show that tetracycline weakens ciprofloxacin activity primarily by increasing survival among cells exposed to the combination. Its growth-dependent SOS analysis identifies distinct dying subpopulations, clarifying why nutrient conditions reshape antibiotic antagonism.

• Sodium Salicylate: NF-κB Control in Tumor Stroma

  2026-08-25

  A translational framework for using sodium salicylate as a mechanistic NF-κB inhibitor in pancreatic tumor microenvironment studies, with practical guidance for separating inflammatory signaling from physical stromal remodeling.

• Vidarabine Monohydrate: From Mechanism to Translation

  2026-08-24

  A translational framework for using Vidarabine monohydrate as a mechanism-led antiviral research compound, with practical guidance for solubility, assay design, herpes simplex virus research, and evidence-based development decisions.

• Leupeptin Hemisulfate: A Better Assay Control

  2026-08-24

  Leupeptin hemisulfate salt is a reversible competitive protease inhibitor with broad utility in protein degradation and cell biology workflows. This guide explains how to deploy Leupeptin as a proteostasis-control reagent alongside modern TET2 metabolite-binding assays without confusing sample preservation with direct enzyme regulation.

• Apicidin Disrupts Oocyte Maturation and Acetylation

  2026-08-23

  The reference study shows that Apicidin exposure compromises oocyte quality by delaying meiotic maturation, disturbing spindle and actin organization, and altering histone and tubulin acetylation. Its in vitro design links meiotic apparatus defects with HDAC1/HDAC3 expression changes, DNA damage, and early apoptosis, providing a mechanistic framework for reproductive toxicology studies.

• Tacrine Hydrochloride Hydrate in AD Assays

  2026-08-22

  Tacrine hydrochloride hydrate is more than a benchmark cholinesterase inhibitor: it is a tool for separating target engagement, cellular protection, and metabolism-aware assay interpretation. This guide connects tacrine pharmacology with lessons from recombinant-enzyme and HPLC-MS research to improve Alzheimer’s disease research workflows.

• Standardized Whole-Blood Immune Metabolism

  2026-08-21

  Zhao and colleagues present a standardized ex vivo whole-blood stimulation protocol for testing how metabolic interventions reshape human immune responses. By combining defined immune stimuli, pathway-directed inhibitors, and cytokine measurements, the workflow reveals selective, stimulus-dependent effects that can support cohort studies and translational immunometabolism research.

• Pulmonary Arterial Remodeling and RV Afterload

  2026-08-20

  This 2025 study uses a subject-specific one-dimensional fluid–structure interaction model to separate how distal pulmonary vascular resistance and proximal arterial compliance shape right ventricular afterload in pulmonary hypertension. Its central finding is that increased distal resistance most strongly raises maximum main pulmonary artery pressure, whereas reduced compliance substantially increases characteristic impedance, providing a mechanistic basis for more targeted interpretation of pulmonary hemodynamics.

• L. reuteri FN041 Remodels Colitis-Linked Microbiota

  2026-08-20

  This study shows that human milk-derived Limosilactobacillus reuteri FN041 reduces disease severity in DSS-induced colitis mice while improving barrier-associated, inflammatory, microbial, and metabolic readouts. Its main contribution is an integrated multi-omics view of probiotic activity, although the findings remain preclinical and do not establish causality or clinical efficacy in ulcerative colitis.

8539 records 1/570 page Next 12345 下5页 Last page